First-in-Human trial tests new hope for tough cancers
Disease control
Not yet recruiting
This is the first study in people to test a new drug called ITC-6146RO for patients with advanced or metastatic cancer who have run out of standard treatment options. The main goals are to find a safe dose and see how the body processes the drug. The study will enroll about 102 a…
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC